Publications by authors named "Uiechan Jeong"

In this study, we created a 3D Artificial Skin Platform that can be used for the treatment of pigmentation by artificially realizing the skin of pregnant women. For the stable realization of 3D artificial skin, a bilayer hydrogel composed of collagen type I and fibrin was designed and applied to the study to reduce the tension-induced contraction of collagen type I, the extracellular matrix (ECM) of artificial skin, by dynamic culture. Oxygen concentration and 17β-Estradiol (E2) concentration, which are highly related to melanin production, were selected as parameters of the pregnancy environment and applied to cell culture.

View Article and Find Full Text PDF
Article Synopsis
  • Drug screening is a critical phase in developing therapeutic interventions, focusing on evaluating substances with medicinal properties efficiently and rapidly.
  • Microfluidic systems, like organ-on-a-chip and tumor-on-a-chip technologies, are revolutionizing drug screening by mimicking human organ functions and enabling fast, low-sample testing with a high degree of genetic similarity to humans.
  • This review highlights the principles, benefits, and challenges of these advanced platforms, discussing their latest innovations and potential for transforming drug discovery and development in the future.*
View Article and Find Full Text PDF

Synopsis of recent research by authors named "Uiechan Jeong"

  • - Uiechan Jeong's recent research primarily focuses on developing innovative biomedical platforms, specifically a 3D Artificial Skin Platform aimed at studying pregnancy-related skin pigmentation.
  • - The 3D skin model employs a bilayer hydrogel to mimic the conditions of pregnant women's skin while investigating factors affecting melanin production, such as oxygen and 17β-Estradiol concentrations.
  • - Additionally, Jeong explores advancements in microfluidic systems for high-throughput drug screening, emphasizing their efficiency and ability to reduce sample consumption in the evaluation of potential therapeutic compounds.